TABLE 5.
Identification of the most discriminant metabolomic variables between AD and CD in post-dialysis and rebound measurements.
| Accurate mass (m/z) | Retention time (min) | Adduct ion | Formula | Identification of variables | Compound class | Fold change (Citrate vs. Acetate) | |
|---|---|---|---|---|---|---|---|
| Metabolite annotation | Confidence level | ||||||
| 114.0919 | 3.3666 | M + H | C6H11NO | 2,5-Dihydro-2,4,5-trimethyloxazole | 1 | Oxazolines | Post-dialysis: 9.27 |
| 2-Acetylpyrrolidine | Pyrrolidines | ||||||
| Epsilon-caprolactam | Caprolactams | ||||||
| 1-Piperidinecarboxaldehyde | Piperidines | ||||||
| M + H-H20 | C6H13NO2 | Aminocaproic acid 6-Deoxyfagomine N-(2-Hydroxyethyl)-morpholine N-(2-hydroxy-2-methylpropyl)acetamide 2-hydroxy-3-(propylamino)propanal N-(3-hydroxy-2-methylpropyl)acetamide, N-(2-Methylpropyl)glycolamide N,N-diethyl-2-oxoethanamine oxide, 2-[Ethyl(2-hydroxyethyl)amino]acetaldehyde2-[ethyl(1-hydroxyethyl)amino]acetaldehyde, 2-(diethylamino)-2-hydroxyacetaldehyde L-Isoleucine, L-Leucine, β-Leucine, D-Leucine, L-Norleucine, L-Alloisoleucine, 3-Aminocaproic acid, N-methylvaline, 4-(dimethylamino)Butanoic acid, N,N-Diethylglycine | 3 | Fatty acids and conjugates | |||
| Piperidines | |||||||
| Morpholines | |||||||
| Alcohols and polyols | |||||||
| Pyrazoles | |||||||
| Carboxylic acid derivatives Amines Amino acids, peptides, and analogues | |||||||
| M + H-H20 | C6H14NO2 | 1-Nitrohexane | 3 | Organic nitro compounds | |||
| Confidence level: 1: identified metabolites, 2: putatively annotated, 3: putatively characterized; 4: unknown | |||||||